Cedric Francois - 16 May 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Issuer symbol
APLS
Transactions as of
16 May 2023
Net transactions value
-$2,436,400
Form type
4
Filing time
18 May 2023, 17:10:56 UTC
Previous filing
28 Apr 2023
Next filing
25 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $80,100 +30,000 +11% $2.67* 304,655 16 May 2023 Direct F5
transaction APLS Common Stock Sale $77,682 -934 -0.31% $83.17 303,721 16 May 2023 Direct F5, F6
transaction APLS Common Stock Sale $150,921 -1,800 -0.59% $83.84 301,921 16 May 2023 Direct F5, F7
transaction APLS Common Stock Sale $1,242,065 -14,611 -4.8% $85.01 287,310 16 May 2023 Direct F5, F8
transaction APLS Common Stock Sale $258,305 -3,007 -1% $85.90 284,303 16 May 2023 Direct F5, F9
transaction APLS Common Stock Sale $655,059 -7,528 -2.6% $87.02 276,775 16 May 2023 Direct F5, F10
transaction APLS Common Stock Sale $185,869 -2,120 -0.77% $87.67 274,655 16 May 2023 Direct F5, F11
transaction APLS Common Stock Options Exercise $53,400 +20,000 +7.3% $2.67* 294,655 17 May 2023 Direct F12
holding APLS Common Stock 382,946 16 May 2023 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2) F1
holding APLS Common Stock 634,211 16 May 2023 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023) F2
holding APLS Common Stock 300,000 16 May 2023 Indirect Owner (The Francois Grossi Trust) F3
holding APLS Common Stock 234,411 16 May 2023 Indirect Owner (The Francois-DuBois Educational Trust) F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -30,000 -8.6% $0.000000 320,000 16 May 2023 Common Stock 30,000 $2.67 Direct F5, F13
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -20,000 -6.2% $0.000000 300,000 17 May 2023 Common Stock 20,000 $2.67 Direct F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
F2 The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F3 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F4 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F5 This is a scheduled exercise & sale from 10b5-1 trading plan.
F6 This transaction was executed in multiple trades at prices ranging from $82.500 - $83.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $83.500 - $84.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 This transaction was executed in multiple trades at prices ranging from $ $84.545 - $85.520. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9 This transaction was executed in multiple trades at prices ranging from $85.550 - $86.540. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10 This transaction was executed in multiple trades at prices ranging from $86.550 - $87.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11 This transaction was executed in multiple trades at prices ranging from $87.570 - $87.795. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F12 This is a scheduled exercise from 10B5-1 trading plan.
F13 This option was granted on December 5, 2013 and fully vested.